It also triggers TGF-β1-dependent NF-κB induction in glioma cells and provokes a more aggressive glioma phenotype by targeting the deubuiquitinase CYLB and protocadherin-8 [315, 316]. The gene discussed is TGFB1; the disease is central nervous system cancer.